Skip to main content
High RiskFDAfda-F-3360-2017OTHER

Publix Greenwise Cashew Butter, NET WT 16 oz (1 lb) 454g, Distributed by Publix Super Markets, Inc, Lakeland, FL 33802

Category
Units Affected
414
Recall Date
June 30, 2017
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3360-2017.

The reason for recall was that some jars of Publix GreenWise Cashew Butter may actually contain Almond Butter.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3360-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Publix Supermarkets, Inc. (deli Kitchen) or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3360-2017.

Publix Supermarkets, Inc. (Deli Kitchen)

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Publix Supermarkets, Inc. (deli Kitchen) Recall FAQ

Publix Supermarkets, Inc. (deli Kitchen) is the subject of a dairy safety report: Publix Greenwise Cashew Butter, NET WT 16 oz (1 lb) 454g, Distributed by Publix Super Markets, Inc, Lakeland, FL 33802. The notice was published on June 30, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 414 units are potentially affected.